St
StrideBio
Durham NCFounded 201860 employees
Private CapbiotechPrivateGenetic Medicine
Platform: AAV Stealth
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sotolucimab | STR-8350 | Phase 2/3 | 1 | LAG-3 | PV | ||
| Fixatuximab | STR-192 | Phase 3 | 3 | GPRC5D | Psoriasis | ||
| Riboosocimab | STR-4038 | Phase 2 | 1 | TYK2 | PVAsthma | ||
| Polamavacamten | STR-3449 | NDA/BLA | 1 | HER2 | Fabry |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)